Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Ispinesib in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
Phase 2 trial of ispinesib in metastatic or unresectable renal cell carcinoma has completed, reporting results in patients with recurrent or…
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating PEG-Interferon alfa-2b in patients with metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects [Phase 3]
Phase 3 trial comparing bevacizumab plus temsirolimus versus bevacizumab plus interferon-alfa in advanced renal cell carcinoma. Results were…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma [Phase 1]
Phase 1 study evaluating the combination of metformin and temsirolimus in patients with metastatic or unresectable solid tumors or lymphoma;…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) [Phase 1]
This Phase 1 trial of MDX-1203 in patients with clear cell renal cell carcinoma and relapsed/refractory B-cell non-Hodgkin lymphoma has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer [EARLY_Phase 1]
A Phase 1 pilot study evaluating denileukin diftitox in combination with high-dose interleukin-2 for metastatic renal cell carcinoma has com…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. [Phase 1]
Phase 1 study of MDX-1411 given every 14 days with pre-medications in clear cell renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2 [Phase 2]
Phase 2 trial update reporting safety and efficacy results for ABX-EGF in patients with advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-05-13Clinical Trial Update: Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics)
A completed clinical trial analyzing the incidence, prevalence, and symptom burden of advanced renal cell carcinoma in a commercially insure…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating temsirolimus and bryostatin-1 in patients with unresectable or metastatic solid tumors, including recurrent melanom…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
A terminated clinical trial evaluated whether Sorafenib or Regorafenib affects P63 expression and keratinocyte differentiation in human skin…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]
Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: RPI.4610 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial update showing RPI.4610 in metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer [Phase 2]
A phase 2 clinical trial evaluating a biological therapy after chemotherapy and peripheral stem cell transplantation in patients with variou…
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer [Phase 2]
This clinical trial investigates ixabepilone for metastatic, recurrent, or unresectable renal cell carcinoma in a Phase 2 study; the trial h…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma [Phase 1]
Phase 1 clinical trial evaluating the combination of Interleukin-12 and Interferon alfa in patients with metastatic renal cell carcinoma and…
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Zoledronate With Atorvastatin in Renal Cell Carcinoma [Phase 2]
Phase 2 trial assessing the combination of zoledronate and atorvastatin in renal cell carcinoma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-03-18Clinical Trial Update: Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma
A completed clinical trial update describing the intake conditions for sunitinib in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 trial results comparing pazopanib to sunitinib in Asian patients with locally advanced or metastatic renal cell carcinoma were repor…
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating AGS-003, an autologous dendritic cell–based immunotherapy, for biologic activity and safety in patients with ne…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib [Phase 3]
Phase 3 trial comparing temsirolimus to sorafenib as second-line therapy in advanced renal cell carcinoma after failure of first-line suniti…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Phase 2]
This update summarizes results from a Phase 2 trial evaluating the combination of bevacizumab (Avastin) and everolimus (RAD001) for advanced…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer [Phase 2]
This Phase 2 clinical trial evaluated the combination of sorafenib and interferon alfa in patients with metastatic or unresectable renal cel…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer [Phase 2]
A Phase 2 trial evaluating erlotinib for locally advanced or metastatic papillary renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of AGS-16M18 in subjects with advanced renal cell carcinoma; the trial was terminat…